Gastroretentive Drug Delivery Systems Outsourcing Market to Grow with a CAGR of 5.51% through 2030

Increasing demand for targeted drug delivery is expected to drive the Global Gastroretentive Drug Delivery Systems Outsourcing Market growth in the forecast period, 2026-2030.

According to TechSci Research report, “Gastroretentive Drug Delivery Systems Outsourcing Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2030”, the Global Gastroretentive Drug Delivery Systems Outsourcing Market stood at USD 1.37 billion in 2024 and is anticipated to grow with a CAGR of 5.51% in the forecast period, 2026-2030. The global pharmaceutical industry is constantly evolving, seeking innovative solutions to enhance drug delivery and improve patient outcomes. Gastroretentive drug delivery systems have emerged as a significant advancement in this endeavor, allowing drugs to remain in the stomach for an extended period. This technology not only improves drug bioavailability but also minimizes side effects and enhances patient compliance. One of the primary drivers of the gastroretentive drug delivery systems outsourcing market is the increasing incidence of gastrointestinal disorders worldwide. Conditions such as gastroesophageal reflux disease (GERD), irritable bowel syndrome (IBS), and peptic ulcers affect millions of people, necessitating advanced drug delivery systems that target specific areas of the gastrointestinal tract. Gastroretentive drug delivery systems provide a viable solution by ensuring that the drug remains in the stomach, allowing for localized treatment and controlled release. This trend is spurring pharmaceutical companies to seek outsourcing services to expedite the development and commercialization of gastroretentive drug formulations.

The global aging population is another significant driver of the gastroretentive drug delivery systems outsourcing market. As people age, they are more susceptible to chronic diseases, including those affecting the gastrointestinal system. An aging demographic creates a higher demand for pharmaceutical interventions, making innovative drug delivery systems more critical. Gastroretentive drug delivery offers the advantage of providing long-lasting therapeutic effects, which can be particularly beneficial for the elderly population. Consequently, pharmaceutical companies are looking to outsource the development of these specialized delivery systems to cater to this growing demographic.

Patient non-compliance with prescribed medications is a widespread issue in healthcare. Many patients struggle to adhere to their medication regimens, often due to the inconvenience and discomfort associated with conventional drug delivery methods. Gastroretentive drug delivery systems address this challenge by providing a more patient-friendly and convenient approach. These systems reduce the frequency of dosing and minimize the need for strict timing, making it easier for patients to adhere to their treatment plans. As patient compliance is a critical factor in achieving successful therapeutic outcomes, pharmaceutical companies are increasingly outsourcing the development of gastroretentive drug delivery systems to improve patient adherence and, ultimately, the effectiveness of their drugs.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Gastroretentive Drug Delivery Systems Outsourcing Market"

The Global Gastroretentive Drug Delivery Systems Outsourcing Market is segmented into Dosage Form, Regional Distribution, And Company.

Based on the Dosage Form, Tablets emerged as the fastest segment in the global market for Global Gastroretentive Drug Delivery Systems Outsourcing Market in the forecast period. Tablets are in a solid-state form, which is ideal for many drug formulations. The solid-state nature allows for more stable drug storage, longer shelf life, and the inclusion of controlled-release technologies. For gastroretentive drug delivery, where controlled and sustained release is often required, the solid format of tablets is advantageous. Tablets can be formulated in various ways to accommodate different types of drugs and drug delivery requirements. Gastroretentive systems can be incorporated into tablet formulations, allowing for customization of drug release profiles, which is important in achieving site-specific drug delivery within the gastrointestinal tract.

Tablets are among the most patient-friendly and convenient dosage forms. They are easy to swallow and do not involve the discomfort associated with injections or the need for special administration devices as with liquid formulations. This ease of administration fosters better patient compliance and encourages pharmaceutical companies to explore innovative drug delivery systems that can be incorporated into tablets..

The Asia Pacific region is showing the fastest growth in the Gastroretentive Drug Delivery Systems (GRDDS) outsourcing market. This rapid expansion can be attributed to factors such as increasing healthcare demands, rising chronic diseases, and a growing emphasis on advanced drug delivery technologies. The region's strong manufacturing base, coupled with a rising number of contract research organizations (CROs) and outsourcing opportunities, is further driving the market. Additionally, the growing adoption of GRDDS for its ability to improve drug bioavailability and reduce side effects is gaining traction in Asia Pacific. With improvements in healthcare infrastructure and regulatory support, the region is positioning itself as a key hub for outsourcing in the GRDDS sector.

Major companies operating in Global Gastroretentive Drug Delivery Systems Outsourcing Market are:

• Catalent, Inc
• Lonza Group
• Evonik Industries AG
• Colorcon
• Quotient Sciences
• AptarGroup, Inc.
• Aenova Holding GmbH
• Evotec SE 
• Vectura Group Ltd
• Ashland Inc.

Download Free Sample Report

Customers can also request for 10% free customization on this report

“The Global Gastroretentive Drug Delivery Systems Outsourcing Market is poised for significant growth in the coming years. The advancements in drug delivery technologies, particularly gastroretentive systems, are driving innovation and spurring pharmaceutical companies to invest in specialized outsourcing services. The emphasis on improved patient compliance, personalized medicine, and patient-centric healthcare further fuels the demand for outsourcing partners with expertise in gastroretentive drug delivery. Regulatory support and a strong focus on research and development also play pivotal roles in propelling the market forward.” said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“Gastroretentive Drug Delivery Systems Outsourcing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Dosage Form (Tablets, Liquid, Microspheres, Capsule, Others) Region and Competition 2020-2030F” has evaluated the future growth potential of Global Gastroretentive Drug Delivery Systems Outsourcing Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Gastroretentive Drug Delivery Systems Outsourcing Market.

Contact

Techsci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +13322586602

Email: sales@techsciresearch.com

Website: www.techsciresearch.com